Stock Markets June 12, 2026 08:29 AM

Rezolve AI Proposes $300 Million Buyback, Shares Rise in Premarket

Board to seek shareholder and court approvals for capital reduction and BTIG-facilitated repurchases; company says valuation does not reflect business strength

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
RZLV

Rezolve AI said its board will ask shareholders to authorize a capital reduction and a $300 million share repurchase arrangement to be executed with BTIG. The announcement preceded a 7.1% jump in the company's shares in premarket trading. The company intends to fund repurchases from cash on hand pending Court approval and is exploring potential non-dilutive financing without assurance of completion.

Rezolve AI Proposes $300 Million Buyback, Shares Rise in Premarket
RZLV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Rezolve AI's board will seek shareholder approval at the June 30, 2026 annual meeting for a capital reduction and a $300 million share repurchase arrangement with BTIG.
  • The company intends to begin repurchases using existing cash reserves after Court approval, and is evaluating potential non-dilutive financing while retaining flexibility for M&A and growth investment.
  • The repurchase program is conditional - it does not obligate the company to buy a set number of shares and may be suspended, modified or discontinued.

Rezolve AI Ltd (NASDAQ:RZLV) saw its shares climb 7.1% in premarket trading Friday after the company disclosed plans for a sizable share repurchase program.

The company's board will ask shareholders at the annual general meeting on June 30, 2026, to approve a capital reduction and an arrangement with BTIG that, if approved, would allow Rezolve AI to repurchase up to $300 million of its ordinary shares. Under the proposed framework, BTIG would buy shares on the open market within agreed pricing parameters and Rezolve AI would subsequently repurchase those shares from BTIG.

Rezolve AI said it expects to begin repurchases only after obtaining the necessary Court approval for the capital reduction, and that it plans to use existing cash reserves to fund initial buybacks. The company also indicated it is assessing potential non-dilutive financing options that could support the program over time, while preserving flexibility to pursue other priorities such as strategic mergers and acquisitions and ongoing investment in growth. The company cautioned that there can be no assurance any such financing will be completed.


Board rationale and approvals

The board described the proposed repurchase program as a response to what it views as a market valuation that does not fully recognize Rezolve AI's business strength or growth prospects. Based on current voting arrangements, the board expects shareholders to approve the proposal at the June meeting. The company anticipates receiving Court approval for the capital reduction by the end of August.

The capital reduction itself requires authorization under the UK Companies Act 2006. The company emphasized that the repurchase program would not obligate it to buy any specified number of shares and that the program could be suspended, modified or discontinued at any time.


Leadership comment

Daniel M. Wagner, Chairman and Chief Executive Officer, said the board believes the current market valuation materially undervalues Rezolve AI and that launching the repurchase program signals confidence in the company's future.


Market and corporate finance context

The proposal links corporate capital allocation, shareholder approval mechanics and judicial sign-off in the UK, with execution to be facilitated by a market intermediary. The company has stated its intention to prioritize both the repurchase program and flexibility for strategic transactions and growth investment, while acknowledging limits on the certainty of external financing.

The full mechanics, timing and ultimate scale of repurchases remain contingent on shareholder approval, Court consent and any future financing decisions.

Risks

  • Court approval for the capital reduction is required under the UK Companies Act 2006 and remains pending - timing and outcome could affect the start of repurchases.
  • Any non-dilutive financing the company evaluates to support the program is not assured to be completed, introducing uncertainty about long-term funding of buybacks.
  • The repurchase arrangement does not compel Rezolve AI to acquire a specific number of shares and may be suspended or altered, creating uncertainty for shareholders about the program's ultimate scale and duration.

More from Stock Markets

Jazz Pharmaceuticals Shares Slip After Zepzelca Misses Primary Endpoint in Phase 3 Lung Cancer Study Jun 12, 2026 Pop Culture Group Shares Collapse After $8M Dilutive Offering Priced at $0.15 Jun 12, 2026 Capital Economics Flags IPO Wave as Potential Stress Test for Equity Markets Jun 12, 2026 HSBC among largest lenders exposed as IFFCO pursues debt restructuring Jun 12, 2026 Mistral AI in Talks to Secure Roughly €3 Billion at About a €20 Billion Valuation Jun 12, 2026